Lento Bio
Lento Bio is a pharmaceutical company focused on developing small-molecule therapeutics targeting aging damage.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), Lento Bio works in biotechnology, life science, pharmaceutical, founded in 2022.
Its activity falls under biotechnology, life science, pharmaceutical; the profile below is assembled from public directory data.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Life Science, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2022 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: lentobio.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account